Problems of cumulative toxicity of radiotherapy and cytostatic chemotherapy in bronchial carcinoma

Onkologie
W Rhomberg

Abstract

The possible toxicities of combined modality therapy in bronchogenic carcinoma are reviewed. Enhancement of local and systemic side effects of each treatment form are the main risks to reduce quality of survival in these patients. Recent studies did not yet resolve the problems of optimal chemotherapy, dose of radiation necessary to obtain complete responses more frequently, or timing of the administration of chemotherapy and radiotherapy. Until significant survival benefits due to combined modality treatment are proven in patients with bronchogenic carcinoma, combined therapy should be given in controlled clinical trials only.

Related Concepts

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.

Related Papers

Nihon Igaku Hōshasen Gakkai zasshi. Nippon acta radiologica
S KikuchiE Hirai
Praxis und Klinik der Pneumologie
H P Heilmann
Casopís lékar̆ů c̆eských
D WeberováJ Simícek
© 2021 Meta ULC. All rights reserved